Alzheimer’s drug from Eli Lilly wins backing of FDA committee – The Washington Post

Alzheimer’s drug from Eli Lilly wins backing of FDA committee  The Washington PostFDA panel votes unanimously for Eli Lilly’s Alzheimer’s treatment  Yahoo FinanceIndependent committee recommends the FDA approve Eli Lilly’s Alzheimer’s drug donanemab  CNNOpinion | An Alzheimer’s Advance, Not a Cure-All  The Wall Street JournalAdvisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug  The New York Times